MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

14 Mar 2016 Evaluate

Glenmark Pharmaceuticals has about a Press Release dated March 14, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets, 2.5 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..